Nichols W W, Ledwith B J, Manam S V, Troilo P J
Merck Research Laboratories, West Point, Pennsylvania 19486, USA.
Ann N Y Acad Sci. 1995 Nov 27;772:30-9. doi: 10.1111/j.1749-6632.1995.tb44729.x.
Studies have been designed to examine the potential integration of DNA vaccines into the host cell genome. This is of concern because of the possibility of insertional mutagenesis resulting in the inactivation of tumor suppressor genes or the activation of oncogenes. The requirements for adequate testing were determined to be (1) a method to purify host cell genomic DNA from nonintegrated free plasmid, (2) a sensitive method to detect integrated plasmid in the purified genomic DNA, and (3) stringent methods to avoid contamination. These requirements were fulfilled by agarose-gel electrophoresis, the polymerase chain reaction, and separation of each activity with stringent handling procedures, respectively. An exploratory experiment was carried out in which mice were injected with 100 micrograms of vaccine plasmid DNA in each quadriceps. Examination of quadriceps and 12 other tissues at several time points failed to reveal any evidence of integration at a sensitivity level that could detect 1 to 7.5 integrations in 150,000 nuclei. A worst-case scenario determined that this would be at least 3 orders of magnitude below the spontaneous mutation frequency.
已开展多项研究来检测DNA疫苗整合至宿主细胞基因组的可能性。这令人担忧,因为可能会发生插入诱变,导致肿瘤抑制基因失活或致癌基因激活。充分检测的要求确定为:(1)从未整合的游离质粒中纯化宿主细胞基因组DNA的方法;(2)检测纯化基因组DNA中整合质粒的灵敏方法;(3)避免污染的严格方法。这些要求分别通过琼脂糖凝胶电泳、聚合酶链反应以及采用严格操作程序分离各项活性得以满足。进行了一项探索性实验,向小鼠每条股四头肌注射100微克疫苗质粒DNA。在多个时间点对股四头肌和其他12个组织进行检测,未发现任何整合迹象,检测灵敏度可达在150,000个细胞核中检测到1至7.5次整合。最坏的情况表明,这至少比自发突变频率低3个数量级。